Business UpdateOct 28, 2026, 07:06 AM
Genprex Research on TUSC2 Gene Featured at Gerontological Society Meeting
AI Summary
Genprex, Inc. announced that research from its collaboration with Meharry Medical College will be presented at the Gerontological Society of America 2026 Annual Scientific Meeting. The research focuses on the TUSC2 gene, used in Genprex's oncology candidate REQORSA, and its role in cellular resilience and aging processes. This work expands the understanding of TUSC2 and REQORSA biology, potentially informing future therapeutic applications beyond oncology, complementing Genprex's existing development in lung cancer and diabetes.
Key Highlights
- Genprex's sponsored research with Meharry Medical College on TUSC2 gene will be featured at GSA 2026 Annual Scientific Meeting.
- Research investigates TUSC2's role in mitochondrial biology, cellular resilience, and aging processes.
- Findings may inform potential future therapeutic applications beyond oncology.
- Genprex is exploring REQORSA's potential relevance to aging-related processes alongside oncology and diabetes priorities.
Price Impact
More from GNPX